Company Moves: The Latest in the Global Generics Market - DCAT Value Chain Insights

Novartis’ decision to spin out Sandoz, its generics and biosimilars business, into a separate, stand-alone company is the latest move in the highly cost-competitive generics market. What was behind Novartis’ decision, and how does it fit with other recent deals?

Global API Market: Crunching the Numbers - DCAT Value Chain Insights

Sustainability, Free Full-Text

Tilley Distribution

the Insights Value Chain. “Where AI, Machine Learning, and…, by Peter Inge

Kwon Kim on LinkedIn: Pharma Industry Outlook: Where is the Growth? - DCAT Value Chain Insights

Neuland Labs

DCAT (Drug, Chemical, & Associated Technologies Association)

Sponsored Content Archives - DCAT Value Chain Insights

Aryaka's Fifth Annual Global State of the WAN Report Reveals Network Insights from 1,350 Global Enterprises - IT Supply Chain

Is Open Collaboration The New Paradigm In Pharmaceutical Manufacturing Innovation